Low-dose aspirin for the prevention of atherosclerotic cardiovascular disease.
Patrono C.
Eur Heart J. 2024 Jul 12;45(27):2362-2376. doi: 10.1093/eurheartj/ehae324.
Autoimmune diseases and atherosclerotic cardiovascular disease.
Porsch F, Binder CJ.
Nat Rev Cardiol. 2024 Nov;21(11):780-807. doi: 10.1038/s41569-024-01045-7. Epub 2024 Jun 27.
Lipoprotein(a): A Genetically Determined, Causal, and Prevalent Risk Factor for Atherosclerotic Cardiovascular Disease: A Scientific Statement From the American Heart Association.
Reyes-Soffer G, Ginsberg HN, Berglund L, Duell PB, Heffron SP, Kamstrup PR, Lloyd-Jones DM, Marcovina SM, Yeang C, Koschinsky ML; American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Cardiovascular Radiology and Intervention; and Council on Peripheral Vascular Disease.
Arterioscler Thromb Vasc Biol. 2022 Jan;42(1):e48-e60. doi: 10.1161/ATV.0000000000000147. Epub 2021 Oct 14.
Trained immunity in atherosclerotic cardiovascular disease.
Riksen NP, Bekkering S, Mulder WJM, Netea MG.
Nat Rev Cardiol. 2023 Dec;20(12):799-811. doi: 10.1038/s41569-023-00894-y. Epub 2023 Jun 15.
Periodontitis and atherosclerotic cardiovascular disease.
Kim JY, Lee K, Lee MG, Kim SJ.
Mol Cells. 2024 Dec;47(12):100146. doi: 10.1016/j.mocell.2024.100146. Epub 2024 Nov 6.
Colchicine in atherosclerotic cardiovascular disease.
Tucker B, Goonetilleke N, Patel S, Keech A.
Heart. 2024 Apr 15;110(9):618-625. doi: 10.1136/heartjnl-2023-323177.
The Molecular Basis of Predicting Atherosclerotic Cardiovascular Disease Risk.
Nayor M, Brown KJ, Vasan RS.
Circ Res. 2021 Jan 22;128(2):287-303. doi: 10.1161/CIRCRESAHA.120.315890. Epub 2021 Jan 21.
Lipoprotein(a) and cardiovascular disease.
Boffa MB, Koschinsky ML.
Biochem J. 2024 Oct 2;481(19):1277-1296. doi: 10.1042/BCJ20240037.
Uncovering atherosclerotic cardiovascular disease by PET imaging.
Maier A, Teunissen AJP, Nauta SA, Lutgens E, Fayad ZA, van Leent MMT.
Nat Rev Cardiol. 2024 Sep;21(9):632-651. doi: 10.1038/s41569-024-01009-x. Epub 2024 Apr 4.
Novel therapeutic targets and emerging treatments for atherosclerotic cardiovascular disease.
Zheng WC, Chan W, Dart A, Shaw JA.
Eur Heart J Cardiovasc Pharmacother. 2024 Jan 5;10(1):53-67. doi: 10.1093/ehjcvp/pvad074.
